Literature DB >> 29044784

Mechanism-Based Inhibitors of the Human Sirtuin 5 Deacylase: Structure-Activity Relationship, Biostructural, and Kinetic Insight.

Nima Rajabi1, Marina Auth1, Kathrin R Troelsen1, Martin Pannek2, Dhaval P Bhatt3, Martin Fontenas1, Matthew D Hirschey3, Clemens Steegborn2, Andreas S Madsen1, Christian A Olsen1.   

Abstract

The sirtuin enzymes are important regulatory deacylases in a variety of biochemical contexts and may therefore be potential therapeutic targets through either activation or inhibition by small molecules. Here, we describe the discovery of the most potent inhibitor of sirtuin 5 (SIRT5) reported to date. We provide rationalization of the mode of binding by solving co-crystal structures of selected inhibitors in complex with both human and zebrafish SIRT5, which provide insight for future optimization of inhibitors with more "drug-like" properties. Importantly, enzyme kinetic evaluation revealed a slow, tight-binding mechanism of inhibition, which is unprecedented for SIRT5. This is important information when applying inhibitors to probe mechanisms in biology.
© 2017 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  deacylases; drug discovery; enzyme inhibitors; posttranslational modifications; sirtuins

Mesh:

Substances:

Year:  2017        PMID: 29044784      PMCID: PMC5814306          DOI: 10.1002/anie.201709050

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  35 in total

1.  Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins.

Authors:  Jessica L Feldman; Josue Baeza; John M Denu
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

2.  Investigating the Sensitivity of NAD+-dependent Sirtuin Deacylation Activities to NADH.

Authors:  Andreas S Madsen; Christian Andersen; Mohammad Daoud; Kristin A Anderson; Jonas S Laursen; Saswati Chakladar; Frank K Huynh; Ana R Colaço; Donald S Backos; Peter Fristrup; Matthew D Hirschey; Christian A Olsen
Journal:  J Biol Chem       Date:  2016-02-09       Impact factor: 5.157

3.  Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.

Authors:  S Imai; C M Armstrong; M Kaeberlein; L Guarente
Journal:  Nature       Date:  2000-02-17       Impact factor: 49.962

4.  Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.

Authors:  Takayoshi Suzuki; Tomomi Asaba; Erika Imai; Hiroki Tsumoto; Hidehiko Nakagawa; Naoki Miyata
Journal:  Bioorg Med Chem Lett       Date:  2009-08-12       Impact factor: 2.823

5.  SIRT5 desuccinylates and activates SOD1 to eliminate ROS.

Authors:  Zhi-Feng Lin; Hong-Bing Xu; Jian-Yun Wang; Qiang Lin; Zhen Ruan; Fa-Bing Liu; Wang Jin; Hai-Hua Huang; Xi Chen
Journal:  Biochem Biophys Res Commun       Date:  2013-10-16       Impact factor: 3.575

6.  Ex-527 inhibits Sirtuins by exploiting their unique NAD+-dependent deacetylation mechanism.

Authors:  Melanie Gertz; Frank Fischer; Giang Thi Tuyet Nguyen; Mahadevan Lakshminarasimhan; Mike Schutkowski; Michael Weyand; Clemens Steegborn
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-09       Impact factor: 11.205

Review 7.  The chemical biology of sirtuins.

Authors:  Bing Chen; Wenwen Zang; Juan Wang; Yajun Huang; Yanhua He; Lingling Yan; Jiajia Liu; Weiping Zheng
Journal:  Chem Soc Rev       Date:  2015-05-08       Impact factor: 54.564

8.  Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase.

Authors:  Jintang Du; Yeyun Zhou; Xiaoyang Su; Jiu Jiu Yu; Saba Khan; Hong Jiang; Jungwoo Kim; Jimin Woo; Jun Huyn Kim; Brian Hyun Choi; Bin He; Wei Chen; Sheng Zhang; Richard A Cerione; Johan Auwerx; Quan Hao; Hening Lin
Journal:  Science       Date:  2011-11-11       Impact factor: 47.728

9.  Desuccinylation of pyruvate kinase M2 by SIRT5 contributes to antioxidant response and tumor growth.

Authors:  Ye Xiangyun; Niu Xiaomin; Gu Linping; Xu Yunhua; Li Ziming; Yu Yongfeng; Chen Zhiwei; Lu Shun
Journal:  Oncotarget       Date:  2017-01-24

10.  SIRT5 promotes IDH2 desuccinylation and G6PD deglutarylation to enhance cellular antioxidant defense.

Authors:  Lisha Zhou; Fang Wang; Renqiang Sun; Xiufei Chen; Mengli Zhang; Qi Xu; Yi Wang; Shiwen Wang; Yue Xiong; Kun-Liang Guan; Pengyuan Yang; Hongxiu Yu; Dan Ye
Journal:  EMBO Rep       Date:  2016-04-09       Impact factor: 9.071

View more
  16 in total

Review 1.  Sirtuin activators and inhibitors: Promises, achievements, and challenges.

Authors:  Han Dai; David A Sinclair; James L Ellis; Clemens Steegborn
Journal:  Pharmacol Ther       Date:  2018-03-22       Impact factor: 12.310

2.  Sirtuin 5 Regulates Proximal Tubule Fatty Acid Oxidation to Protect against AKI.

Authors:  Takuto Chiba; Kevin D Peasley; Kasey R Cargill; Katherine V Maringer; Sivakama S Bharathi; Elina Mukherjee; Yuxun Zhang; Anja Holtz; Nathan Basisty; Shiva D Yagobian; Birgit Schilling; Eric S Goetzman; Sunder Sims-Lucas
Journal:  J Am Soc Nephrol       Date:  2019-10-01       Impact factor: 10.121

Review 3.  Sirtuin modulators: past, present, and future perspectives.

Authors:  Francesco Fiorentino; Nicola Mautone; Martina Menna; Francesca D'Acunzo; Antonello Mai; Dante Rotili
Journal:  Future Med Chem       Date:  2022-05-18       Impact factor: 4.767

Review 4.  Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology.

Authors:  Surinder Kumar; David B Lombard
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04-11       Impact factor: 8.250

5.  SIRT5 IS A DRUGGABLE METABOLIC VULNERABILITY IN ACUTE MYELOID LEUKEMIA.

Authors:  Anca Franzini; Anthony D Pomicter; Dongqing Yan; Brayden J Halverson; Orlando Antelope; Clinton C Mason; Jonathan M Ahmann; Anna V Senina; Nadeem A Vellore; Courtney L Jones; Matthew S Zabriskie; Hein Than; Michael J Xiao; Alexandria van Scoyk; Ami B Patel; Phillip M Clair; William L Heaton; Shawn C Owen; Joshua L Andersen; Christina M Egbert; Julie A Reisz; Angelo D'Alessandro; James E Cox; Kevin C Gantz; Hannah M Redwine; Siddharth M Iyer; Jamshid S Khorashad; Nima Rajabi; Christian A Olsen; Thomas O'Hare; Michael W Deininger
Journal:  Blood Cancer Discov       Date:  2019-12-02

6.  Sirtuin 5 Deficiency Does Not Compromise Innate Immune Responses to Bacterial Infections.

Authors:  Tytti Heinonen; Eleonora Ciarlo; Charlotte Théroude; Aimilia Pelekanou; Jacobus Herderschee; Didier Le Roy; Thierry Roger
Journal:  Front Immunol       Date:  2018-11-20       Impact factor: 7.561

Review 7.  Sirtuins play critical and diverse roles in acute kidney injury.

Authors:  Kevin Peasley; Takuto Chiba; Eric Goetzman; Sunder Sims-Lucas
Journal:  Pediatr Nephrol       Date:  2021-01-07       Impact factor: 3.714

8.  SIRT5 is a proviral factor that interacts with SARS-CoV-2 Nsp14 protein.

Authors:  Marius Walter; Irene P Chen; Albert Vallejo-Gracia; Ik-Jung Kim; Olga Bielska; Victor L Lam; Jennifer M Hayashi; Andrew Cruz; Samah Shah; John D Gross; Nevan J Krogan; Birgit Schilling; Melanie Ott; Eric Verdin
Journal:  bioRxiv       Date:  2022-01-05

9.  Development of activity-based probes for the protein deacylase Sirt1.

Authors:  Christopher J Goetz; Daniel J Sprague; Brian C Smith
Journal:  Bioorg Chem       Date:  2020-08-26       Impact factor: 5.275

Review 10.  The timeline of epigenetic drug discovery: from reality to dreams.

Authors:  A Ganesan; Paola B Arimondo; Marianne G Rots; Carmen Jeronimo; María Berdasco
Journal:  Clin Epigenetics       Date:  2019-12-02       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.